The EU budget has been increased by €6.2 billion to finance emergency costs associated with the Coronavirus pandemic. This was stated in a statement published on the website of the EU Council on September 11.
“The revised budget increases the costs: for the development and implementation of coronavirus vaccine (€ 1.09 billion); investment initiatives Corona Response and for the fight against the crisis due to COVID-19 (€ 5.1 billion),” – says the report.
It is stressed that EU member states are working to strengthen national health systems and to contain the virus, as well as to mitigate the socio-economic impact of the pandemic.
Earlier, on August 14, it became known that the European Commission concluded the first agreement with the pharmaceutical company AstraZeneca to purchase 300 million doses of potential vaccine against coronavirus.